Search results
Nick Palmeri
Author
Author(s):
Harriette Van Spall
,
Milton Packer
Added:
1 year ago
AHA Conference 2024 — New insights into the SUMMIT trial, investigating tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) and obesity.Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Milton Packer (Baylor Heart and Vascular Institute, US) to discuss the findings from the randomized, double-blind, phase 3 SUMMIT trial (NCT04847557) investigating…
View more
Medhat K Soliman
Research Area(s) / Expertise:
Job title: Associate Staff Physician, Cleveland Clinic Abu Dhabi
Author
Author(s):
Patricia Campbell
,
Paul Kalra
Added:
1 year ago
In this Meet the Experts session, from e-SPACE Heart Failure 2024, Dr Patricia Campbell and Prof Paul Kalra share their expert perspectives on the use of IV iron in clinical practice.
View more
Razvan I Radu
Research Area(s) / Expertise:
Author
Oliviana Geavlete
Research Area(s) / Expertise:
Author
Gian-Battista Chierchia
Research Area(s) / Expertise:
Author
Benjamin O’Brien
Research Area(s) / Expertise:
Job title: Director of the Departments of Cardiac Anesthesiology and Intensive Care Medicine
Author
Added:
5 months ago
Source:
Radcliffe Cardiology
Intensive blood pressure (BP) control is beneficial for high-risk hypertensive patients, regardless of their frailty status, according to a new post hoc analysis of the ESPRIT trial.¹ The findings suggest that even severely frail patients can safely achieve cardiovascular benefits from a lower systolic BP target.MethodologyThis analysis was conducted on data from the ESPRIT (Effects of intensive…
View more
e-SPACE HF 2024 – Day Two
Author(s):
Clara Saldarriaga, Gianluigi Savarese, Javed Butler
Start date:
Oct 19, 2024
Broadcast